Company Anadan-Pharm Srl with Fiscal Code 18994280
recorded a turnover of 2024 of
113.024,
with a net profit of
7.202
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Anadan-Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
114.207
109.319
119.456
110.191
110.241
113.158
130.280
147.246
126.375
113.024
Total Income - EUR
114.207
109.319
119.457
110.191
110.952
113.274
130.280
147.247
126.376
113.024
Total Expenses - EUR
108.142
101.815
130.882
108.580
105.833
108.205
120.531
139.731
119.097
103.640
Gross Profit/Loss - EUR
6.065
7.503
-11.425
1.612
5.119
5.070
9.749
7.516
7.279
9.384
Net Profit/Loss - EUR
5.488
6.303
-12.510
510
4.011
3.989
8.446
6.117
6.078
7.202
Employees
3
2
3
2
2
2
2
2
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -10.1%, from 126.375 euro in the year 2023, to 113.024 euro in 2024.
The Net Profit increased by 1.157 euro, from 6.078 euro in 2023, to 7.202 in the last year.
Check the financial reports for the company - Anadan-Pharm Srl
Financial Rating - ANADAN-PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Anadan-Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Anadan-Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Anadan-Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
40.698 euro in 2024 which includes Inventories of
16.976 euro, Receivables of
20.516 euro and cash availability of
3.206 euro.
The company's Equity was valued at
10.843 euro, while total Liabilities amounted to
35.663 euro.
Equity increased by 165 euro, from 10.738 euro in 2023, to 10.843 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Anadan-Pharm Srl